HIGHLIGHTS
- who: Isaias Hernu00e1ndez-Verdin from the Published in partnership with The Hormel Institute, University of Minnesota have published the article: Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response, in the Journal: (JOURNAL)
- what: As the effect was tightly marked only in Ipi-Naive patients, the authors focused the subsequent analysis on only this group. The authors propose a model in which AID ICN has higher probabilities of being recognized by T-cells, triggering selective expression CXCL13, previously found to be a marker of antigen reactive CD8 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.